This announcement is based on a press release statement from Silo Pharma. With a current ratio of 7.9, the company maintains strong liquidity to fund its development pipeline, though analysts tracked ...
Last week, patent data tracking firm IFI CLAIMS published its annual rankings of the Top 50 U.S. Patent Assignees and the Top ...
Honigman attorneys explain a process for applying Pannu factors to inventions that use AI when considering whether an ...
Revocation petition can be sustained even after expiry of patent: Delhi High Court: Gireesh Babu, New Delhi Wednesday, January 22, 2025, 08:00 Hrs [IST] The High Court of Delhi ha ...
The U.S. Patent and Trademark Office (USPTO) recently announced an official Artificial Intelligence Strategy that outlines ...
Earlier this month, the trademark for Utah Yetis was refused by the United States Patent and Trademark Office due to a ...
The Federal Circuit has issued a precedential decision reversing a lower court’s decision that certain claims of Novartis’s ...